Pages that link to "Q28270514"
Jump to navigation
Jump to search
The following pages link to Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944) (Q28270514):
Displaying 4 items.
- Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience (Q33412047) (← links)
- A molecular analysis provides novel insights into androgen receptor signalling in breast cancer (Q35189443) (← links)
- Primary therapy in breast cancer: what have we learned from landmark trials? (Q38155673) (← links)
- Increased efficacy of a dose-dense regimen of neoadjuvant chemotherapy in breast carcinoma: a retrospective analysis. (Q54525386) (← links)